Spencer Lee Sells 1,000 Shares of Chemed (NYSE:CHE) Stock

Chemed Corporation (NYSE:CHE) EVP Spencer Lee sold 1,000 shares of the stock in a transaction on Friday, August 21st. The stock was sold at an average price of $541.04, for a total value of $541,040.00. Following the sale, the executive vice president owned 13,912 shares in the company, valued at $7,526,948.48. The trade was a 6.71% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Chemed Price Performance

Shares of Chemed stock traded up $0.95 during trading on Monday, reaching $541.52. The company’s stock had a trading volume of 21,011 shares, compared to its average volume of 215,475. The stock has a 50-day moving average price of $499.24 and a two-hundred day moving average price of $446.50. The company has a current ratio of 0.91, a quick ratio of 0.89 and a debt-to-equity ratio of 0.17. Chemed Corporation has a one year low of $365.20 and a one year high of $557.00. The stock has a market capitalization of $7.08 billion, a P/E ratio of 27.21, a price-to-earnings-growth ratio of 2.05 and a beta of 0.51.

Chemed (NYSE:CHE) last announced its quarterly earnings data on Tuesday, July 28th. The company reported $6.06 EPS for the quarter, beating analysts’ consensus estimates of $5.60 by $0.46. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The firm had revenue of $673.25 million for the quarter, compared to analyst estimates of $665.04 million. During the same period last year, the company earned $4.27 EPS. The business’s quarterly revenue was up 8.8% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. As a group, sell-side analysts anticipate that Chemed Corporation will post 23.18 EPS for the current fiscal year.

Chemed Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 3rd. Shareholders of record on Monday, August 17th will be given a dividend of $0.70 per share. This represents a $2.80 annualized dividend and a yield of 0.5%. This is a boost from Chemed’s previous quarterly dividend of $0.60. The ex-dividend date is Monday, August 17th. Chemed’s dividend payout ratio (DPR) is 14.06%.

Analyst Ratings Changes

A number of equities analysts have issued reports on the company. Wall Street Zen upgraded Chemed from a “hold” rating to a “strong-buy” rating in a report on Saturday, August 1st. Bank of America reissued a “neutral” rating on shares of Chemed in a report on Wednesday, July 29th. Oppenheimer raised their target price on shares of Chemed from $500.00 to $590.00 and gave the stock an “outperform” rating in a report on Friday, July 31st. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Finally, Weiss Ratings upgraded Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, July 17th. One analyst has rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $530.75.

Hedge Funds Weigh In On Chemed

A number of large investors have recently bought and sold shares of the business. Commonwealth Equity Services LLC boosted its stake in shares of Chemed by 3.1% during the fourth quarter. Commonwealth Equity Services LLC now owns 734 shares of the company’s stock valued at $314,000 after purchasing an additional 22 shares during the period. Cim LLC boosted its stake in Chemed by 1.1% in the 3rd quarter. Cim LLC now owns 2,139 shares of the company’s stock worth $958,000 after purchasing an additional 24 shares in the last quarter. Eukles Asset Management lifted its holdings in shares of Chemed by 0.4% during the fourth quarter. Eukles Asset Management now owns 6,056 shares of the company’s stock worth $2,591,000 after purchasing an additional 25 shares during the period. MassMutual Private Wealth & Trust FSB boosted its holdings in Chemed by 65.3% in the second quarter. MassMutual Private Wealth & Trust FSB now owns 81 shares of the company’s stock valued at $38,000 after purchasing an additional 32 shares during the last quarter. Finally, EverSource Wealth Advisors LLC boosted its holdings in Chemed by 9.4% during the first quarter. EverSource Wealth Advisors LLC now owns 406 shares of the company’s stock worth $153,000 after buying an additional 35 shares in the last quarter. Institutional investors own 95.85% of the company’s stock.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.